Because insurance companies and Medicare will no longer reimburse the costs associated with HAI’s, the financial burden, estimated at $14,000 per infection, falls on the patient or hospital. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. This literature shall NOT operate as permission, recommendation, or inducement to practice any patented invention without permission of the patent owner.

Each Party shall be liable to the other Party/ies for any damages it causes the other Party/ies by any breach of these Clauses. b. The same shall apply to any copies of the data.] The same shall apply to any copies of the data.

Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of the unavailable information. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.

They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of the unavailable information.

If any term in this Privacy Statement is unacceptable to you, please do not use the Website or provide any personal information. Please contact us as detailed below with any questions.   We will take all steps reasonably necessary to ensure that your personal information is treated securely and subject to appropriate safeguards in accordance with this Privacy Statement and applicable legislation.

Proprietà Intellettuale Buyer assumes all risk of infringement of third-party L'Acquirente assume qualsivoglia rischio relativo a intellectual property rights by reason of any use Buyer makes of the Product in combination with other substances or in the operation of any process, and all infringement arising out of Seller’s compliance with Buyer’s designs, specifications or instructions, and Buyer shall defend, indemnify and hold Seller harmless from and against the same. Seller may, during any period of shortage due to any cause, prorate and/or allocate its supply of such materials among itself for its own consumption, its subsidiaries, its affiliated companies, its accepted orders, its contract customers, and its regular customers not then under contract in such a manner as may be deemed fair and reasonable by Seller. Buyer will sign a reasonable confidentiality agreement upon request and ensure its employees are bound by at least equally restrictive confidentiality obligations as those stated herein.

Buyer assumes all risk of infringement of third- party intellectual property rights by reason of any use Buyer makes of the Product in combination with other substances or in the operation of any process, and all infringement arising out of Seller’s compliance with Buyer’s designs, specifications or instructions, and Buyer shall defend, indemnify and hold Seller harmless from and against the same. Seller may, during any period of shortage due to any cause, prorate, and allocate its supply of such materials among itself for its own consumption, its subsidiaries, affiliated companies, its accepted orders, contract customers, and its regular customers not then under contract in such a manner as may be deemed fair and reasonable by Seller. Buyer will sign a reasonable confidentiality agreement upon request and ensure its employees are bound by at least equally restrictive confidentiality obligations as those stated herein. .

The Governance and Corporate Responsibility Committee in making its recommendation, and the Board in making its decision, may consider any factors or other information that it considers appropriate, including, without limitation, the reasons (if any) given by shareholders as to why they withheld their votes, the qualifications of the tendering director and his or her contributions to the Board and the Company, and the results of the most recent evaluation of the tendering director’s performance by the other members of the Board. The Board will promptly disclose (a) its decision whether to accept or reject the director’s tendered resignation and (b) if applicable, the reasons for rejecting the tendered resignation. The Compensation Committee reviews market data for director compensation to ensure that the Company’s director compensation is reasonable and competitive in relation to similar companies.

Seller makes no representation or warranty of any kind with respect to the Product, express or implied, respecting merchantability or fitness for any particular purpose, whether used alone or in combination with any other material or in any process, and neither party has relied on any statement outside of these terms. Buyer assumes all risk of infringement of third-party intellectual property rights by reason of any use Buyer makes of the Product in combination with other substances or in the operation of any process, and all infringement arising out of Seller’s compliance with Buyer’s designs, specifications or instructions, and Buyer shall defend, indemnify and hold Seller harmless from and against the same. Seller may, during any period of shortage due to any cause, prorate, and allocate its supply of such materials among itself for its own consumption, its subsidiaries, affiliated companies, its accepted orders, contract customers, and its regular customers not then under contract in such a manner as may be deemed fair and reasonable by Seller.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of the unavailable information.